SURI Fees and Costs — Simplify Propel Opportunities ETF

Data updated: 2026-09-11

The net expense ratio is 2.56%: a 2.75% management fee plus 0.05% other expenses, less a 0.25% fee waiver. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $128K in broker commissions, 0.1753% of average net assets, and portfolio turnover was 22%.

SURI Fees and Expenses

Annual operating expenses and sales charges of SURI. Prospectus, as of May 31, 2026.

Annual operating expenses
Management fee2.75%
12b-1 fee0.00%
Other expenses0.05%
Gross expense ratio2.81%
Fee waiver−0.25%
Net expense ratio2.56%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentNo

SURI Costs Over Time

On $10,000 invested in SURI, assuming 5% a year before costs, total costs come to $1,653 over 5 years, cutting the return by 2.87% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 2.56%)$269$824$1,402
Trading costs (broker commissions)$18$56$96
Lost growth on money paid in costs$0$44$154
Total costs$287$924$1,653
Value after costs$10,213$10,652$11,110
Impact on return, per year2.87%2.87%2.87%

SURI Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending June 30, 2026.

  • Explicit cost rate (commissions ÷ average net assets): 0.1753%
  • Total broker commissions: $128K
  • Bought from dealers (principal trades, not a cost): $589.2M
  • Portfolio turnover (prospectus): 22%
  • Securities lending: none during the year

SURI Agency Brokers

Commissions paid.

BrokerAmountShare
BTIG, LLC$75K58.55%
JONESTRADING$38K29.68%
VIRTU AMERICAS LLC$14K11.04%
WALLACHBETH CAPITAL, LLC$4930.38%
BOFA SECURITIES, INC.$4400.34%

SURI Dealer Counterparties

Securities bought directly from dealers (principal trades).

BrokerAmountShare
MORGAN STANLEY & CO. LLC$559.7M95.11%
AKERO THERAPEUTICS INC$7.9M1.34%
PIPER SANDLER & CO.$7.0M1.19%
SVB LEERINK LLC$4.7M0.79%
OPPENHEIMER & CO. INC.$4.4M0.74%
LEER FINANCIAL WEALTH MANAGEMENT$1.4M0.25%
TD SECURITIES (USA) LLC$947K0.16%
The Bank of New York Mellon$900K0.15%
JEFFERIES LLC$900K0.15%
GUGGENHEIM SECURITIES, LLC$662K0.11%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.